Health Care
By Digital Look
Date: Friday 26 May 2017
LONDON (ShareCast) - (ShareCast News) - Advanced Oncotherapy has drawn net proceeds of £1.235m in the third tranche of its Bracknor financing.
The company is a developer of next-generation proton therapy systems for cancer treatment.
In previous statements, Advanced Oncotherapy said proceeds from the Bracknor financing would continue to be allocated to its projects and for general working capital purposes.
At 14:18 BST, shares in Advanced Oncotherapy were down 4.49% at 21.25p each.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 1.93p |
Closing Price Change | 0.000p |
% Change | 0.00 % |
52 Week High | 25.00p |
52 Week Low | 1.75p |
Volume | 0 |
Shares Issued | 542.57m |
Market Cap | £10.44m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research